Besides, the XELOX regimen has more potential than SOX regimen to induce immunogenic tumor cells death and release tumor antigens that are taken up by the surrounding immune cells, resulting in CD8+ T cells activation and expansion. This evidence concerns the gene CD8A and neoplasm.